1. Home
  2. IMRN vs CJET Comparison

IMRN vs CJET Comparison

Compare IMRN & CJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • CJET
  • Stock Information
  • Founded
  • IMRN 1994
  • CJET 2009
  • Country
  • IMRN Australia
  • CJET China
  • Employees
  • IMRN N/A
  • CJET N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • CJET Auto Manufacturing
  • Sector
  • IMRN Health Care
  • CJET Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • CJET Nasdaq
  • Market Cap
  • IMRN 10.1M
  • CJET 8.3M
  • IPO Year
  • IMRN N/A
  • CJET N/A
  • Fundamental
  • Price
  • IMRN $1.72
  • CJET $1.87
  • Analyst Decision
  • IMRN Strong Buy
  • CJET
  • Analyst Count
  • IMRN 1
  • CJET 0
  • Target Price
  • IMRN $5.00
  • CJET N/A
  • AVG Volume (30 Days)
  • IMRN 22.7K
  • CJET 184.9K
  • Earning Date
  • IMRN 05-06-2025
  • CJET 04-29-2025
  • Dividend Yield
  • IMRN N/A
  • CJET N/A
  • EPS Growth
  • IMRN N/A
  • CJET N/A
  • EPS
  • IMRN N/A
  • CJET N/A
  • Revenue
  • IMRN $4,048,286.00
  • CJET $10,275,000.00
  • Revenue This Year
  • IMRN N/A
  • CJET N/A
  • Revenue Next Year
  • IMRN N/A
  • CJET N/A
  • P/E Ratio
  • IMRN N/A
  • CJET N/A
  • Revenue Growth
  • IMRN 82.90
  • CJET 31.31
  • 52 Week Low
  • IMRN $1.60
  • CJET $1.09
  • 52 Week High
  • IMRN $2.87
  • CJET $23.94
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 46.67
  • CJET 51.23
  • Support Level
  • IMRN $1.64
  • CJET $1.68
  • Resistance Level
  • IMRN $1.91
  • CJET $2.00
  • Average True Range (ATR)
  • IMRN 0.16
  • CJET 0.22
  • MACD
  • IMRN 0.00
  • CJET -0.01
  • Stochastic Oscillator
  • IMRN 31.00
  • CJET 48.83

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About CJET Chijet Motor Company Inc.

Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.

Share on Social Networks: